| 2026-06-17 | FDA Drug | FDA Recall: Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL | Fresenius Kabi USA, LLC | Class III | N/A |
| 2026-06-10 | FDA Device | FDA Recall: LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005. | Fresenius Kabi USA, LLC | Class I | N/A |
| 2026-06-10 | FDA Device | FDA Recall: The Large Volume Pump (LVP) of the Ivenix Infusion System (IIS). Model Number: LVP-0004. | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-06-10 | FDA Device | FDA Recall: Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004 | Fresenius Kabi USA, LLC | Class I | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freef | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Freseni | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freefle | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freef | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL fre | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freef | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freefle | Fresenius Kabi USA, LLC | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: 0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Frankl | Fresenius Kabi USA, LLC | Class II | N/A |